Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?
Crossref DOI link: https://doi.org/10.1007/s40261-016-0414-y
Published Online: 2016-05-27
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marcellusi, Andrea
Viti, Raffaella
Damele, Francesco
Cammà , Calogero
Taliani, Gloria
Mennini, Francesco Saverio
Text and Data Mining valid from 2016-05-27